5-benzyl-2-hydrazino-6-methylpyrimidin-4(3H)-one, 95.0%, 500mg

(R)-tert-Butyl 4-isobutyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide, 95%, 1g

tert-Butyl 4-(4-(hydroxymethyl)phenyl)piperazine-1-carboxylate, 95%, 250mg

4-Bromo-3-(dimethylsulfamoyl)benzoic acid, 97%, 100mg

Sodium 4-Hydroxybenzenesulfonate>98.0%(HPLC)(T)500g

[(2S)-2-METHYLOXETAN-2-YL]METHANOL, 95%, 500mg

(2-Chloro-6-methyl-pyrimidin-4-yl)-methyl-amine, 95.0%, 5g

[2-(2-fluorophenoxy)phenyl]methanol, 100mg

1-(4-BROMOPHENYL)-2-[(3-METHOXYPHENYL)THIO]-ETHANONE, 95.0%, 250mg

(tert-Butoxycarbonyl)-D-histidine>98.0%(HPLC)(T)1g

1-(Quinolin-8-yl)ethanamine dihydrochloride, 95%, 250mg

Diéthylène glycol, min 99%, pour synthèse, 25 l, emballage plastique.

3-Ethoxy-N,2,2-trimethylcyclobutan-1-amine, 98%, 500mg